Back to Search
Start Over
Switch from etanercept to efalizumab in a psoriatic patient with HCV infection: a case report.
- Source :
-
Dermatologic Therapy . Jul/Aug2009, Vol. 22 Issue 4, p386-390. 5p. 4 Color Photographs, 2 Graphs. - Publication Year :
- 2009
-
Abstract
- Psoriasis vulgaris is a chronic dermatosis and is a widespread dematological disease. The most represented lesions are erythemato-squamous plaques with a tendency to cover large body areas with a great impairment of normal activities and a poor quality of life. Very often psoriasis is associated to other illnesses and the dermatologist has to be aware that comorbidities have to be taken in account for a successfull treatment of the disease. We report a case of a patient affected by severe psoriasis and HCV infection. He underwent a first treatment with etenarcept with good clinical results and no change of his viral load. When etenarcept became ineffective, he received efalizumab, with a good control of his dermatological condition and a reduction of the viral load. [ABSTRACT FROM AUTHOR]
- Subjects :
- *CASE studies
*ETANERCEPT
*EFALIZUMAB
*PSORIASIS treatment
*HEPATITIS C virus
Subjects
Details
- Language :
- English
- ISSN :
- 13960296
- Volume :
- 22
- Issue :
- 4
- Database :
- Academic Search Index
- Journal :
- Dermatologic Therapy
- Publication Type :
- Academic Journal
- Accession number :
- 42874770
- Full Text :
- https://doi.org/10.1111/j.1529-8019.2009.01251.x